7 completed, 2 recruiting, 1 terminated. 5 Phase 4, 3 Phase 2, 2 Phase 3, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Recruiting 1 |
| Phase 2 | 3 | Completed 1, Recruiting 1, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
| Phase 1 | 1 | Recruiting 1 |
Follow Saline Waters: new trials by email Literature Review of Saline Waters trials Research Report on Saline Waters
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bisphosphonate Prior to Parathyroidectomy in Primary Hyperparathyroidism Zoledronic acid 4 mg, Natriumklorid 9 mg/ml, Fresenius Kabi - Primary Hyperparathyroidism | Phase 4 | Recruiting | University of Aarhus | 140 | 2025-03-01 | 2026-10-01 |
| Intraglandular Treatment With Adipose-derived Mesenchymal Stem Cells in Patients With Xerostomia Due to Sjögren's Disease MSC, Saline Water (Control) - Sjorgren's Syndrome | Phase 1 / Phase 2 | Recruiting | Copenhagen University Hospital, Rigshospitalet | 40 | 2025-01-21 | 2025-02-03 |
| Botulinum Toxin A in Frequent and Chronic Tension-type Headache Botulinum Toxin Type A in saline water, Isotone saline water - Tension-Type Headache | Phase 3 | Completed | Helse Nord-Trøndelag HF | 66 | 2022-10-03 | 2025-03-13 |
| Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal Carcinomatosis Pasireotide 0.9 MG/ML, Saline water - Peritoneal Carcinomatosis | Phase 2 | Terminated | Gustave Roussy, Cancer Campus, Grand Paris | 6 | 2020-09-03 | 2024-02-08 |
| Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ), Prevnar13, Pediarix - Infections, Meningococcal | Phase 3 | Completed | GlaxoSmithKline | 1196 | 2018-07-27 | 2026-08-20 |
| Reversing the Effects of 0.5% Bupivacaine OraVerse, Saline Water (Control) - Anesthesia, Local | Phase 4 | Completed | Dalhousie University | 44 | 2017-02-10 | 2020-01-29 |
| Evaluation of Intraarticular Tranexamic Acid to Reduction of Total Blood Loss Following Knee-Arthroplasty Tranexamic Acid, Saline water - Blood Loss, Postoperative Blood Loss | Phase 4 | Completed | Hvidovre University Hospital | 60 | 2014-01-01 | 2015-08-17 |
| Pain Relieving Efficacy of TAP Block in Patients After Laparoscopic Gastric Bypass. Placebo: sterile normal saline, Marcaine - Pain, Obesity | Phase 4 | Completed | Funch-Jensen, Peter, M.D., D.M.Sc. | 80 | 2011-02-01 | 2014-03-26 |
| Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients Area cleaned with saline water and occluded with Tegaderm, Area cleaned with saline water, Area cleaned with Ethyl alcohol solution - Acne Vulgaris | Phase 2 | Completed | Photocure | 20 | 2010-08-01 | 2014-05-20 |
| Fibrin Sealant in Bilateral Simultaneous Total Knee Arthroplasty With Focus on Blood Loss, Pain, Swelling and Strength Fibrin sealant, Saline water - Blood Loss | Phase 4 | Completed | Hvidovre University Hospital | 48 | 2010-08-01 | 2015-04-22 |
Hemorrhage (2) · Acne Vulgaris (1) · Hyperparathyroidism, Primary (1) · Meningitis (1) · Meningitis, Meningococcal (1) · Meningococcal Infections (1) · Obesity (1) · Pain (1) · Pain, Postoperative (1) · Peritoneal Neoplasms (1) · Postoperative Hemorrhage (1) · Sjogren's Syndrome (1) · Tension-Type Headache (1) · Xerostomia (1)
Hvidovre University Hospital (2) · Copenhagen University Hospital, Rigshospitalet (1) · Dalhousie University (1) · Funch-Jensen, Peter, M.D., D.M.Sc. (1) · GlaxoSmithKline (1) · Gustave Roussy, Cancer Campus, Grand Paris (1) · Helse Nord-Trøndelag HF (1) · Photocure (1) · University of Aarhus (1)
Denmark (5) · United States (2) · Canada (1) · France (1) · Norway (1) · Puerto Rico (1)
Christian Skovgaard Nielsen, M.D (1) · Henrik Husted, M.D. (1) · Henrik Husted, PhD (1) · Lars Rejnmark, Professor (1) · Michael T. Jarratt, M.D. (1) · Norunn Hanssen Hestvik (1) · Peter Funch-Jensen, D.M.Sc. (1) · Pierre-Luc Michaud, DMD, MSc, FRCDC (1)
2019 (2), 2016 (1), 2023 (1)